The polo-like kinase inhibitor BI 2536 exhibits potent activity against malignant plasma cells and represents a novel therapy in multiple myeloma
Autor: | Stewart, Helen J., Kishikova, Lyudmila, Powell, Fiona L., Wheatley, Sally P., Chevassut, Timothy J. ∗ |
---|---|
Zdroj: | In Experimental Hematology 2011 39(3):330-338 |
Databáze: | ScienceDirect |
Externí odkaz: |